(DICHIARAZIONE PUBBLICA DELL’EMEA )
Il Comitato scientifico dell’EMEA ha concluso che comportamento correlato al suicidio e ostilita’ sono stati osservati nei trial clinici piu’ frequentemente in bambini e adolescenti trattati con antidepressivi, rispetto a quelli che avevano ricevuto il placebo.
Related posts
MIAMI, FL - MARCH 23: Bottles of antidepressant pills Wellbutrin (L-R) , Paxil, Lexapro, Effexor, Zoloft and Fluoxetine are shown March 23, 2004 photographed in Miami, Florida. The Food and Drug Administration asked makers of popular antidepressants to add or strengthen suicide-related warnings on their labels as well as the possibility of worsening depression especially at the beginning of treatment or when the doses are increased or decreased. (Photo Illustration by Joe Raedle/Getty Images)
